Clinical trial
Extension Study of Patients With Infantile-Onset Pompe Disease Who Were…
NCT00125879 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00125879 |
|---|---|
| Title | Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602 |
| Official title | A Long-Term Continuation Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602 |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Glycogen Storage Disease Type II |
| Intervention type | Biological |
| Interventions | Myozyme |
| Enrollment | 16 |
| Start date | Jun 1, 2005 |
| Primary completion | Jun 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Aug 2, 2005 |
| Last update posted | Feb 6, 2014 |
| Countries | France, Germany, Israel, Italy, Netherlands, Taiwan, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: